Table 1 Characteristics of the included studies for normal breast epithelium, DCIS, DCIS-adjoining invasive breast cancer, MICB and invasive breast cancer

From: A systematic review to establish the frequency of cyclooxygenase-2 expression in normal breast epithelium, ductal carcinoma in situ, microinvasive carcinoma of the breast and invasive breast cancer

Study

Location

Number of samples included (n)

COX-2 positive (n)

COX-2 positive (%)

Normal breast

Cho et al (2006)

Korea

15

1

6.7

Zhao et al (2008)

USA

19

19

100.0

DCIS

Perrone et al (2005)

Italy

49

31

63.3

Cho et al (2006)

Korea

30

19

63.3

Kulkarni et al (2008)

USA

59

27

45.8

de la Torre et al (2010)

Spain

52

28

53.8

Kerlikowske et al (2010)

USA

279

124

44.4

DCIS-adjoining invasive breast cancer

Leo et al (2006)

Germany

29

16

55.2

MICB

de la Torre et al (2010)

Spain

40

30

74.0

Invasive breast cancer

Ristimaki et al (2002)

Finland

1576

589

37.4

Denkert et al (2003)

Germany

221

80

36.2

Spizzo et al (2003)

Austria

212

103

48.6

Wulfing et al (2003)

Germany

192

78

40.6

Witton et al (2004)

UK

179

38

21.2

Sivula et al (2005)

Finland

231

70

30.3

Surowiak et al (2005)

Poland

104

46

44.2

Gunnarsson et al (2006)

Sweden

284

108

38.0

Schmitz et al (2006)

Germany

113

49

43.4

Yamamoto et al (2008)

Japan

171

97

56.7

Zhao et al (2008)

USA

108

46

42.6

Darb-Esfahani et al (2009)

Germany

101

74

73.3

  1. Abbreviations: COX2=cyclooxygenase 2; DCIS=ductal carcinoma in situ of breast; MCIB=microinvasive carcinoma of the breast.